NDC 61314-543 – Tyruko

Natalizumab 300 mg/15mL · Injection · Intravenous

Human Prescription Drug

Product NDC61314-543

Product details

Brand name
Tyruko
Generic name
Natalizumab-sztn
Labeler
Sandoz Inc
Dosage form
Injection
Route
Intravenous
Marketing category
BLA · BLA761322
Marketed since
November 17, 2025
Listing expires
December 31, 2027
Pharmacologic class
Integrin Receptor Antagonist

Active ingredients

Uses, dosage, side effects and warnings for Tyruko →

Package NDC codes (1)

Package NDCDescriptionSince
61314-543-941 VIAL, SINGLE-DOSE in 1 CARTON (61314-543-94) / 15 mL in 1 VIAL, SINGLE-DOSENov 17, 2025